Perceived COVID-19 risk and testing experiences in the San Ysidro U.S./Mexico border region.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 101554668 Publication Model: Print Cited Medium: Internet ISSN: 1613-9860 (Electronic) Linking ISSN: 16139860 NLM ISO Abbreviation: Transl Behav Med Subsets: MEDLINE
    • Publication Information:
      Publication: 2018- : [Oxford] : Oxford University Press
      Original Publication: New York : Springer
    • Subject Terms:
    • Abstract:
      Racial and ethnic disparities in COVID-19 incidence are pronounced in underserved U.S./Mexico border communities. Working and living environments in these communities can lead to increased risk of COVID-19 infection and transmission, and this increased risk is exacerbated by lack of access to testing. As part of designing a community and culturally tailored COVID-19 testing program, we surveyed community members in the San Ysidro border region. The purpose of our study was to characterize knowledge, attitudes, and beliefs of prenatal patients, prenatal caregivers, and pediatric caregivers at a Federally Qualified Health Center (FHQC) in the San Ysidro region regarding perceived risk of COVID-19 infection and access to testing. A cross-sectional survey was used to collect information on experiences accessing COVID-19 testing and perceived risk of COVID-19 infection within San Ysidro between December 29, 2020 and April 2, 2021. A total of 179 surveys were analyzed. Most participants identified as female (85%) and as Mexican/Mexican American (75%). Over half (56%) were between the age of 25 and 34 years old. Perceived Risk: 37% reported moderate to high risk of COVID-19 infection, whereas 50% reported their risk low to none. Testing Experience: Approximately 68% reported previously being tested for COVID-19. Among those tested, 97% reported having very easy or easy access to testing. Reasons for not testing included limited appointment availability, cost, not feeling sick, and concern about risk of infection while at a testing facility. This study is an important first step to understand the COVID-19 risk perceptions and testing access among patients and community members living near the U.S./Mexico border in San Ysidro, California.
      (© The Author(s) 2023. Published by Oxford University Press on behalf of the Society of Behavioral Medicine.)
    • References:
      Am J Obstet Gynecol MFM. 2021 Mar;3(2):100295. (PMID: 33516986)
      J Matern Fetal Neonatal Med. 2022 Jan;35(2):205-211. (PMID: 32419558)
      Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):520-522. (PMID: 32541960)
      J Cell Mol Med. 2020 Oct;24(19):11038-11045. (PMID: 32816409)
      Health Soc Care Community. 2022 Sep;30(5):e1907-e1916. (PMID: 34719072)
      J Racial Ethn Health Disparities. 2021 Jun;8(3):543-546. (PMID: 33783755)
      Health Serv Res. 2022 Jun;57 Suppl 1:149-157. (PMID: 35243622)
      JAMA Netw Open. 2021 Mar 1;4(3):e210684. (PMID: 33704475)
      Ann N Y Acad Sci. 2011 Mar;1221:80-7. (PMID: 21401634)
      Cureus. 2020 Sep 29;12(9):e10707. (PMID: 33014665)
      Physiol Rev. 2021 Jan 1;101(1):303-318. (PMID: 32969772)
      Tour Manag Perspect. 2020 Jul;35:100717. (PMID: 32834958)
      Circulation. 2021 Jun 15;143(24):2332-2342. (PMID: 33200953)
      PLoS Med. 2020 Sep 22;17(9):e1003379. (PMID: 32960880)
      N Engl J Med. 2020 Jun 25;382(26):2534-2543. (PMID: 32459916)
      JAMA. 2022 Feb 22;327(8):748-759. (PMID: 35129581)
      Int J Gynaecol Obstet. 2020 Jul;150(1):121-123. (PMID: 32342500)
      Eur J Obstet Gynecol Reprod Biol. 2020 Jun;249:96-97. (PMID: 32317197)
      Hum Vaccin Immunother. 2020 Dec 1;16(12):2932-2937. (PMID: 33175602)
      BJOG. 2022 Jul;129(8):1289-1297. (PMID: 35157346)
      BMJ. 2020 Jun 23;369:m2503. (PMID: 32576558)
      Int J Soc Psychiatry. 2021 Jun;67(4):344-350. (PMID: 32815434)
      Lat Stud. 2021;19(3):400-404. (PMID: 34121932)
      Eur J Epidemiol. 2021 Feb;36(2):197-211. (PMID: 33649879)
      Lancet. 2020 May 2;395(10234):1421-1422. (PMID: 32330427)
      Prev Chronic Dis. 2020 Jun 25;17:E49. (PMID: 32584753)
      Am J Respir Crit Care Med. 2020 Oct 1;202(7):943-949. (PMID: 32677842)
      JAMA. 2020 Jun 23;323(24):2466-2467. (PMID: 32391864)
    • Grant Information:
      P42 ES010337 United States ES NIEHS NIH HHS; United States NH NIH HHS
    • Contributed Indexing:
      Keywords: Access; COVID-19; Disease burden; Risk perception; Testing strategies; U.S./Mexico border
      Local Abstract: [plain-language-summary] COVID-19 testing strategies that fail to incorporate culturally competent methods to reach traditionally underserved communities can lead to persistent transmission and increased infection rates. During the early stages of the COVID-19 pandemic, we surveyed 179 people living in a community with high burden of COVID-19 infection about their perception of infection risk and their experiences accessing testing. Capturing and understanding these community perceptions on COVID-19 risk are vital when developing a testing program that is accessible and appropriate for the target population. In our study, we found half of survey respondents thought their risk of COVID-19 infection as low to none and over half of respondents stated they had already been tested for COVID-19. These findings provide insight to the beliefs of individuals who live and seek health care in communities with high rates of COVID-19 infection and will help guide the design and implementation of culturally tailored testing strategies.
    • Publication Date:
      Date Created: 20230331 Date Completed: 20230711 Latest Revision: 20240515
    • Publication Date:
      20240515
    • Accession Number:
      PMC10314726
    • Accession Number:
      10.1093/tbm/ibac120
    • Accession Number:
      36999822